Antiplatelet therapy has been catching up with the pace of heparin and coumarin management, sometimes outpacing it. Now the laboratory and clinician must catch on the hop. The 51 internationally recognized experts contributing to this book can help them. The extraordinary introductory color plates become especially useful for clarifying the many functions of platelets heretofore only skimpily described in most textbooks.
Implementing safe and effective coagulation control over the continuing ever-challenging spectrum of cardiovascular disorders is provided by the 3 experienced clinician-authors of Management Strategies in Antithrombotic Therapy from the Cleveland Clinic. This excellent monograph elucidates commonly used antiplatelet agents, antithrombin, and fibrinolytic agents in its first section and explains appropriate current management for myocardial infarction and venous thrombotic and thromboembolic disorders in its second section. The book also includes complications of heparin exposure including heparin-induced For the coagulationist, this new book can update the skills necessary to respond to the demands of surgeons and angiographers who use improved drugs and techniques to minimize thrombotic risks inherent in their procedures. Particularly useful are guides for the use of some of the new devices providing information on platelet function for the clinical laboratory that heretofore were available only in research laboratories. Guidance to documenting whether heparin-induced thrombocytopenia (HIT) and thrombocytopenia with thrombosis (HITT) is present or absent becomes particularly important for the ordinary clinical laboratory, when distinction determines whether alternative anticoagulation is necessary. The complexities of interactions between drugs and the coagulation system as well as the complexity of the interaction of plasma constituents and platelets in clotting disorders become apparent in this fine text.
For the cardiovascular surgeon and the angiologist, this new book opens new vistas both diagnostically and therapeutically. Appropriate regimens of antithrombotic therapies, recommended by the American Heart Association, the American College of Cardiology, and the American College of Chest Physicians, are considered in detail here and rapidly available.
Book Reviews
Book Reviews 497 thrombocytopenia both without (HIT) and with thrombosis (HITT).
A great number of confusing abbreviations and acronyms appearing in the current literature are explained, helping the reader through the minefield of 35 current trial studies.
For both the laboratorian and the clinician, the book shows what one needs to achieve for an optimal outcome for patients with threatened or active thrombotic and embolic problems, incorporating current evidence-based recommendation.
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